TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
85.25
-8.77 (-9.33%)
At close: Nov 20, 2026, 4:00 PM EST
85.05
-0.20 (-0.23%)
After-hours: Nov 20, 2026, 7:59 PM EST
TransMedics Group Market Cap
TransMedics Group has a market cap or net worth of $2.96 billion as of November 20, 2026. It is the 4,915th most valuable company in the world and the 1,465th biggest in the United States. Its market cap has decreased by 35.08% in one year.
Market Cap
2.96B
Enterprise Value
3.34B
1-Year Change
-35.08%
Global Rank
Country Rank
#1,465 United States
Category
ChartMarket Cap Chart
Since May 2, 2019, TransMedics Group's market cap has increased from $452.48M to $2.96B, an increase of 554.41%. That is a compound annual growth rate of 28.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 2.96B | -28.77% |
| Dec 31, 2025 | 4.16B | 98.67% |
| Dec 31, 2024 | 2.09B | -18.79% |
| Dec 29, 2023 | 2.58B | 30.78% |
| Dec 30, 2022 | 1.97B | 270.34% |
| Dec 31, 2021 | 532.04M | -1.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 2, 2019 (IPO) | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Haemonetics | 5.59B |
| LivaNova | 5.21B |
| Axogen | 3.40B |
| iRhythm Holdings | 3.19B |
| Neogen | 2.42B |
| UFP Technologies | 2.37B |
| Alamar Biosciences | 2.12B |
| Establishment Labs Holdings | 2.11B |